BIOMAT Database Logo BIOMAT Database Logo

Familial early infantile myasthenia gravis. 1953

B BORNSTEIN

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001049 Apnea A transient absence of spontaneous respiration. Apneas

Related Publications

B BORNSTEIN
[Familial infantile myasthenia gravis].
May 1991, Harefuah,
B BORNSTEIN
Infantile myasthenia gravis.
September 1981, Indian pediatrics,
B BORNSTEIN
Familial infantile myasthenia gravis: a preventable cause of sudden death.
February 1985, Southern medical journal,
B BORNSTEIN
Familial myasthenia gravis.
September 1982, Journal of neurology, neurosurgery, and psychiatry,
B BORNSTEIN
Familial myasthenia gravis.
September 1967, British medical journal,
B BORNSTEIN
Familial infantile myasthenia.
February 1980, Archives of neurology,
B BORNSTEIN
Familial autoimmune myasthenia gravis.
March 1994, Neurology,
B BORNSTEIN
Familial pseudoparalytic myasthenia gravis.
January 1952, Schweizer Archiv fur Neurologie und Psychiatrie. Archives suisses de neurologie et de psychiatrie. Archivio svizzero di neurologia e psichiatria,
B BORNSTEIN
Familial autoimmune myasthenia gravis.
April 2001, Singapore medical journal,
B BORNSTEIN
Familial infantile myasthenia gravis: a cause of sudden death in young children.
September 1975, The Journal of pediatrics,
Copied contents to your clipboard!